Reaction

Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,406 reports · 60 co-occurring drugs

As of the last recalculation, Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis appears in 2,406 FAERS reports alongside 60 co-occurring drug terms. The strongest observed disproportionality signal is TOBRAMYCIN SOLUTION (PRR 36.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Tobramycin Solution	49	36.0	36.1
Tobramycin Sulfate	49	34.9	35.1
Minocycline	42	31.7	31.8
Methimazole	25	27.8	27.9
Sofosbuvir	48	21.5	21.5
Isosorbide Mononitrate	50	21.3	21.3
Docusate Sodium 100Mg	56	20.7	20.8
Tobramycin	49	18.0	18.0
Anakinra	33	17.4	17.5
Febuxostat Tablets 40 Mg	16	13.7	13.7
Febuxostat Tablets 80 Mg	16	13.7	13.7
Clonidine	73	12.7	12.7
Doxycycline Hyclate	79	10.4	10.4
Doxycycline	78	10.2	10.2
Azathioprine	94	9.6	9.6
Metoprolol Succinate Er Tablets	65	9.2	9.2
Apixaban	65	8.6	8.6
Docusate Sodium	56	8.6	8.6
Febuxostat	16	8.3	8.3
Calcitriol Capsules 0.25 Mcg	19	8.3	8.3
Calcitriol Capsules 0.5 Mcg	19	8.3	8.3
Rituximab	187	8.2	8.2
Calcitriol	19	8.2	8.2
Cyclophosphamide Injection, Solution	157	8.1	8.1
Cyclophosphamide	157	8.1	8.1
Cyclophosphamide For Injection	157	8.1	8.1
Terazosin Hydrochloride	8	7.8	7.8
Anastrozole Tablets	19	7.7	7.7
Tretinoin	7	7.5	7.5
Piperacillin And Tazobactam	11	7.5	7.5
Ceftriaxone	25	6.7	6.7
Metoprolol Succinate	65	6.6	6.6
Lisinopril And Hydrochlorothiazide Tablets	6	6.6	6.6
Labetalol	10	6.5	6.5
Nifedipine	35	6.5	6.5
Pyrazinamide	7	6.5	6.5
Atovaquone	6	6.5	6.5
Sulfasalazine	57	6.4	6.4
Ribavirin	47	6.4	6.4
Doxazosin	20	6.2	6.2
Piperacillin Sodium And Tazobactam Sodium	14	6.2	6.2
Nintedanib	22	6.1	6.1
Carvedilol	91	6.0	6.0
Rifampicin	7	6.0	6.0
Ceftriaxone Sodium	26	5.9	5.9
Piperacillin Sodium,Tazobactam Sodium	18	5.9	5.9
Golimumab	56	5.8	5.8
Amlodipine	165	5.6	5.6
Insulin Glargine-Yfgn	14	5.6	5.6
Anti-Thymocyte Globulin (Rabbit)	5	5.4	5.4
Metoprolol Tartrate Injection	113	5.4	5.4
Lisinopril And Hydrochlorothiazide	6	5.1	5.1
Romosozumab-Aqqg	7	4.5	4.5
Dolutegravir Sodium	4	3.8	3.8
Abatacept	53	3.4	3.4
Emtricitabine And Tenofovir Alafenamide	4	3.1	3.1
Erlotinib Hydrochloride	4	2.8	2.8
Erlotinib	3	2.7	2.7
Minoxidil Foam 5% (Womens)	6	1.6	1.6
Minoxidil	6	1.2	1.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.